Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
基本信息
- 批准号:8840592
- 负责人:
- 金额:$ 37.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-01 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAdjuvantAnti-Inflammatory AgentsAnti-inflammatoryAntibiotic ResistanceAspergillusBiological AssayBlindnessBone MarrowCandidaCandida albicansCellsChromatinCorneaDataDendritic CellsDevelopmentEpithelialEpithelial CellsEpitheliumFlagellinGene ExpressionGenesGenomicsGoalsGrantHistone Deacetylase InhibitorHomeostasisHourImmuneImmune responseInfectionInflammationInflammation MediatorsInflammatoryInvadedKeratitisKnock-outKnockout MiceKnowledgeLeadLigandsLightMediatingMediator of activation proteinMethodsModalityModelingMolecular StructureMucosal ImmunityMusMyeloid CellsNatural ImmunityNeutrophil InfiltrationPlayProductionPseudomonas aeruginosaRecovery of FunctionRecruitment ActivityRegulationResistanceResistance to infectionRoleSeveritiesSignal TransductionSmall Interfering RNATLR2 geneTestingTherapeuticToll-Like Receptor 5Toll-like receptorsTopical applicationTransgenic Miceactivating transcription factor 3antimicrobial peptidebasecathelicidinchemokinechromatin immunoprecipitationchromatin modificationchromatin remodelingcorneal epitheliumcytokineinnovationmacrophagemicrobialmouse modelneutrophilocular surfacepathogenpreventpromoterprophylacticreconstitutionresponsetranscription factor
项目摘要
Microbial keratitis is a common cause of vision loss. The cornea is exquisitely sensitive to inflammation-
mediated damage and therefore has strong innate defenses. However, when the epithelial barrier function is
breached, opportunistic bacterial and fungal pathogens can gain access to the epithelial cell layers and
colonize in the cornea, leading to infection. During the initial grant period, flagellin, the ligand of Toll-like
receptor 5 (TLR5), was used to fortify corneal innate immunity and render resistance to a broad spectrum of
keratitis causing pathogens, including Pseudomonas aeruginosa, Candida albicans and Aspergillus
fumigates. This highly inducible and robust innate mucosal protection can be attributed to flagellin-induced
genomic reprogramming in the epithelium which, in turn, interacts with professional immune cells to control
inflammation and to eradicate invading pathogens. The hypothesis in this application is that flagellin, through
TLR5, stimulates protective corneal innate mucosal immunity that involves epithelial cells, infiltrated PMNs,
and activated dendritic cells, collectively conferring robust resistance to microbial keratitis. Three specific
aims are proposed to test this hypothesis: 1) To determine how flagellin-induced reprogramming is regulated
in corneal epithelial cells and in the cornea. This can be assessed by using the chromatin
immunoprecipitation assay and histone deacetylase inhibitors for gene-specific chromatin modification and by
using siRNA and knockout mice for delineating the role of activating transcription factor-3, a transcription
factor induced by fg, in regulating the innate immune response in the cornea. 2) To determine how the
epithelium participates in and coordinates flagellin-induced mucosal innate immune defense against microbial
keratitis. The role of the epithelium and its interaction with dendritic cells in innate defense will be determined
by using various transgenic and knockout mice, bone marrow reconstitution, and cell depletion. 3) To
determine how flagellin induces protection against non-flagellated pathogens in the cornea. The therapeutic
potential of flagellin and its mechanisms of action will be characterized by using mouse models of fungal
keratitis (Candida and Aspergillus as pathogens and post-infection topical flagellin application) and double
TLR knockout mice. The results of the proposed study should shed light on corneal innate immunity and its
induction, and may lead to the development of new prophylactic/therapeutic modalities for preventing and
treating microbial keratitis.
细菌性角膜炎是视力丧失的常见原因。角膜对炎症非常敏感
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fu-Shin X Yu其他文献
Fu-Shin X Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fu-Shin X Yu', 18)}}的其他基金
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8248480 - 财政年份:2008
- 资助金额:
$ 37.24万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7923002 - 财政年份:2008
- 资助金额:
$ 37.24万 - 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8655872 - 财政年份:2008
- 资助金额:
$ 37.24万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7615662 - 财政年份:2008
- 资助金额:
$ 37.24万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7844845 - 财政年份:2008
- 资助金额:
$ 37.24万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
8332413 - 财政年份:2008
- 资助金额:
$ 37.24万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7461874 - 财政年份:2008
- 资助金额:
$ 37.24万 - 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8445213 - 财政年份:2008
- 资助金额:
$ 37.24万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 37.24万 - 项目类别:














{{item.name}}会员




